HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nivolumab-induced anti-aminoacyl-tRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma.

AuthorsK Shikano, K Kaneko, K Kaburaki, K Isobe, K Kawabe, S Homma, S Kawai, T Nanki
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 49 Issue 1 Pg. 82-83 (Jan 2020) ISSN: 1502-7732 [Electronic] England
PMID31135242 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies
  • Antineoplastic Agents, Immunological
  • Nivolumab
  • Amino Acyl-tRNA Synthetases
Topics
  • Adenocarcinoma of Lung (complications, diagnosis, drug therapy)
  • Aged, 80 and over
  • Amino Acyl-tRNA Synthetases (immunology)
  • Antibodies (blood)
  • Antineoplastic Agents, Immunological (adverse effects, therapeutic use)
  • Electromyography
  • Humans
  • Lung Diseases, Interstitial (diagnosis, etiology)
  • Lung Neoplasms (complications, diagnosis, drug therapy)
  • Magnetic Resonance Imaging
  • Male
  • Nivolumab (adverse effects, therapeutic use)
  • Polymyositis (chemically induced, complications, immunology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: